Literature DB >> 21383048

Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD.

Cristian Turato1, Alessandra Biasiolo, Paolo Pengo, Vladimir Frecer, Santina Quarta, Silvano Fasolato, Mariagrazia Ruvoletto, Luca Beneduce, Jessica Zuin, Giorgio Fassina, Angelo Gatta, Patrizia Pontisso.   

Abstract

SERPINB3 has been found in chronic liver damage and hepatocellular carcinoma, but not in normal liver. By direct mRNA sequencing, a new SERPINB3 polymorphism (SCCA-PD) has been identified, presenting the substitution Gly351Ala in the reactive center loop of the protein. The prevalence of the SCCA-PD isoform has been found to be significantly higher in patients with cirrhosis than in patients with chronic liver disease and in normal subjects. The aim of this study was to investigate the biological and functional activity of SERPINB3 isoforms using in vitro models. HepG2 and Huh7 cells lines were transfected with plasmid vectors containing wild-type SERPINB3 or its polymorphic variant SCCA-PD and their expression at transcriptional and protein level was determined. To assess the functional activity, both recombinant proteins were produced and kinetic analysis was carried out using papain and cathepsin-L as target proteases. In addition, the inhibition of JNK kinase activity by SERPINB3 isoforms was assessed. The crystal structure of wild-type SERPINB3 at 2.7 Å resolution was used for preparation of refined 3D models of the two isoforms. The results showed that transcriptional activity and protein expression of the two isoforms were similar in both transfected cell lines. Both SERPINB3 preparations exerted a dose-dependent protease inhibitory activity, but the effect of SCCA-PD was higher than that of the wild-type isoform. This result was supported by 3D modelling, where increased hydrophobic profile of the SCCA-PD isoform, introduced by the G351A mutation, was detected. In addition, at high protein concentration, SCCA-PD revealed a 16% higher inhibitory effect on c-Jun phosphorylation by JNK1, compared with wild-type SERPINB3. In conclusion, the single amino acid substitution in the SERPINB3 reactive site loop improves the functional activity of SCCA-PD isoform. This different antiprotease activity might favor disease progression in patients carrying this polymorphism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383048     DOI: 10.1258/ebm.2011.010229

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  5 in total

1.  SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3).

Authors:  Cristian Turato; Patrizia Pontisso
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2015

2.  The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker.

Authors:  Gian Paolo Fadini; Mattia Albiero; Renato Millioni; Nicol Poncina; Mauro Rigato; Rachele Scotton; Federico Boscari; Enrico Brocco; Giorgio Arrigoni; Gianmarco Villano; Cristian Turato; Alessandra Biasiolo; Patrizia Pontisso; Angelo Avogaro
Journal:  Diabetologia       Date:  2014-06-25       Impact factor: 10.122

3.  Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.

Authors:  Cristian Turato; Melania Scarpa; Andromachi Kotsafti; Andrea Cappon; Santina Quarta; Alessandra Biasiolo; Francesco Cavallin; Elisabetta Trevellin; Vincenza Guzzardo; Matteo Fassan; Vanna Chiarion-Sileni; Carlo Castoro; Massimo Rugge; Roberto Vettor; Marco Scarpa; Patrizia Pontisso
Journal:  Cancer Sci       Date:  2019-04-15       Impact factor: 6.716

4.  SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.

Authors:  Cristian Turato; Stefania Cannito; Davide Simonato; Gianmarco Villano; Elisabetta Morello; Liliana Terrin; Santina Quarta; Alessandra Biasiolo; Mariagrazia Ruvoletto; Andrea Martini; Silvano Fasolato; Giacomo Zanus; Umberto Cillo; Angelo Gatta; Maurizio Parola; Patrizia Pontisso
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

5.  SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype.

Authors:  Mariele Gatto; Roberto Luisetto; Anna Ghirardello; Laura Cavicchioli; Gaia Codolo; Alessandra Biasiolo; Giuseppe Maggioni; Francesca Saccon; Marianna Beggio; Andrea Cappon; Roberta Venturini; Patrizia Pontisso; Andrea Doria
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.